Despite decades of research, development of a treatment for stimulant use disorder remains elusive. Experts are now hunkering down to come with new approaches to overcome hurdles in clinical trial design and the selection of study endpoints.
“I’m quite sure we’ve been doing it wrong
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Pink Sheet for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?